NASDAQ •
Healthcare •
Biotechnology •
Quote as of 07/24/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization7.69 mln
Float0.28 mln
1-Year Forecast
12.00
Transformational upside
Relative Strength
82
/ 100
Strongly outperforming
Debt / Equity
-0.62
Negative equity
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Payout Ratio
0%
No payout
Business Description
Lakewood-Amedex Biotherapeutics Inc. is a Florida-based company focused on creating new medicines to fight bacterial infections. Its lead group of treatments, called Bisphosphocins, targets a wide range of infections in areas such as the skin, bladder, and lungs. The company is currently running a mid-stage clinical trial for Nu-3, a topical treatment designed to address infected foot wounds in diabetic patients.
